|
CN111909144A
|
|
Quinazoline DNA-PK inhibitor
|
|
CN111909147A
|
|
DNA-PK inhibitors
|
|
CN111635373A
|
|
Polycyclic sulfonamide ROR gamma modulators
|
|
CN112047948A
|
|
Kras mutant inhibitors
|
|
CN111978296A
|
|
Ketohexokinase inhibitors and uses thereof
|
|
CN110498804A
|
|
The new application of quinazoline derivative species tyrosine kinase inhibitor
|
|
CN111825595A
|
|
Sodium channel blockers
|
|
CN111777620A
|
|
Novel use of tyrosine kinase inhibitor
|
|
CN111773225A
|
|
KRAS and its mutant expression inhibitor
|
|
CN111777621A
|
|
Novel application of quinazoline derivative tyrosine kinase inhibitor
|
|
CN111592541A
|
|
Macrocyclic kinase inhibitors and uses thereof
|
|
CN111499591A
|
|
ROR gamma modulators
|
|
CN109568321A
|
|
ROR gamma modulators
|
|
CN111410651A
|
|
Salts of tyrosine kinase inhibitors and crystalline forms thereof
|
|
CN110294742A
|
|
And ring class ASK1 inhibitor and its application
|
|
CN110698471A
|
|
ASK1 inhibitor and application thereof
|
|
WO2019007418A1
|
|
Fxr receptor agonist
|
|
CN110294746A
|
|
A kind of new ASK1 inhibitor and its application
|
|
CN107721986A
|
|
The crystal formation of quinazolines tyrosine kinase inhibitor
|
|
WO2018028673A1
|
|
Salt of quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereof
|
